Parkside Financial Bank & Trust’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
AC
Parkside Financial Bank & Trust's HRMY Position: Q2 2026 in Review
Parkside Financial Bank & Trust reduced its Harmony Biosciences (HRMY) stake by 82% in Q2 2026, selling an estimated $12.7K and leaving 90 shares worth $3.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2024.
Parkside Financial Bank & Trust first reported a position in HRMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $55.6K in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.
- Parkside Financial Bank & Trust held 90 shares of Harmony Biosciences worth $3.28K as of Q2 2026.
- Parkside Financial Bank & Trust sold 404 Harmony Biosciences shares in Q2 2026, an estimated $12.7K.
- Harmony Biosciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2024 holding.
- Parkside Financial Bank & Trust first reported a position in Harmony Biosciences in Q4 2021 and has held it in 18 quarters since.
- Parkside Financial Bank & Trust's Harmony Biosciences position peaked at $55.6K in Q4 2025.
- 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.